Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ascendis Pharma AS

ASND
Current price
119.51 USD +1.29 USD (+1.09%)
Last closed 129.41 USD
ISIN US04351P1012
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 8 163 271 168 USD
Yield for 12 month -16.63 %
1Y
3Y
5Y
10Y
15Y
ASND
21.11.2021 - 28.11.2021

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Address: Tuborg Boulevard 12, Hellerup, Denmark, 2900

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

191.88 USD

P/E ratio

Dividend Yield

Current Year

+280 184 214 USD

Last Year

+53 757 703 USD

Current Quarter

+60 752 906 USD

Last Quarter

+37 815 488 USD

Current Year

+233 547 773 USD

Last Year

+41 007 923 USD

Current Quarter

+48 986 384 USD

Last Quarter

+25 771 636 USD

Key Figures ASND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -347 192 992 USD
Operating Margin TTM -370.18 %
PE Ratio
Return On Assets TTM -27.92 %
PEG Ratio
Return On Equity TTM -818.43 %
Wall Street Target Price 191.88 USD
Revenue TTM 317 628 000 USD
Book Value -2.57 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -24.00 %
Dividend Yield
Gross Profit TTM 39 037 000 USD
Earnings per share -7.84 USD
Diluted Eps TTM -7.84 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -154.12 %

Dividend Analytics ASND

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ASND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ASND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 24.22
Price Sales TTM 25.70
Enterprise Value EBITDA -20.75
Price Book MRQ 14.55

Financials ASND

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ASND

For 52 weeks

111.09 USD 161.00 USD
50 Day MA 129.27 USD
Shares Short Prior Month 3 574 434
200 Day MA 135.39 USD
Short Ratio 8.50
Shares Short 3 767 316
Short Percent 8.03 %